Paul Gilman, MD

Headshot of Paul Gilman, MD

Resident Faculty


Dr. Gilman is the Director of the Clinical Research Center at LIMR.


  • Director, Clinical Research Center
  • Director, Center for Clinical Cancer Research


  • Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292). Kemeny MM, Zhao F, … Gilman PB, et al. Ann Surg Oncol. 2023 Feb;30(2):1099-1109. doi: 10.1245/s10434-022-12705-8
  • A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment. Weiss MC, Hibbs JE, Buckley ME, ... Meske SW, Aliano-Ruiz KE, McHugh TW, Larson SL, … Gilman PB, et al. Cancer. 2022 Jan 1;128(1):160-168.
  • Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial. Mariotti V, … Gilman P, et al. JAMA Oncol. 2021 Jan 1;7(1):61-69.
  • McCourt DD, Parikh K, Brady AL, Wang Y, Kennedy J, Buckley ME, Ali ZA, Shevade AL, Gilman PB, Wallon UM. The quest for reliable prediction of chemotherapy-induced delayed nausea among breast cancer patients. J Unexplored Med Data 2019;4:6.
  • Fox E, Oliver T, Rowe M, Thomas S, Zakharia Y, Gilman PB, Muller AJ, Prendergast GC. Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer. Front Oncol. 2018 Sep 11;8:370.
  • Kutner T, Kunkel E, Wang Y, George K, Zeger EL, Ali ZA, Prendergast GC, Gilman PB, Wallon UM. Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea. Support Care Cancer 2017 Feb;25(2):581-87.
  • Waks AG, Lennon J, Yadav BS, … Gilman PB, et al. Metastasis to the Cervix Uteri 15 Years After Treatment of Lobular Carcinoma of the Breast. Semin Oncol 2015 Aug;42(4):e81-94.

Education and Training


  • MD
    Jefferson Medical College

Academic Titles

  • Director, Clinical Research Center
  • Director, Center for Clinical Cancer Research